Showing results (5311-5320 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 7, 2003
Modification of intestinal flora in the treatment of inflammatory bowel diseaseOsamu Kanauchi, Keiichi Mitsuyama, Yoshio Araki, et al.Current Pharmaceutical Design|February 7, 2003
Enteral and parenteral nutrition therapy for Crohn's diseaseTomoyuki Tsujikawa, Akira Andoh, Yoshihide FujiyamaCurrent Pharmaceutical Design|February 7, 2003
Natural killer T cells as targets for therapeutic intervention in autoimmune diseasesM T Wilson, L Van KaerCurrent Pharmaceutical Design|February 7, 2003
Treatment of refractory autoimmune diseases with ablative immunotherapy using monoclonal antibodies and/or high dose chemotherapy with hematopoietic stem cell supportYossi Cohen, Aaron Polliack, Arnon NaglerCurrent Pharmaceutical Design|June 8, 2002
Protein flexibility is an important component of structure-based drug discoveryHeather A CarlsonCurrent Pharmaceutical Design|June 8, 2002
Scintigraphic imaging of HSVtk gene therapyErik F J de Vries, Anne Rixt Buursma, Geke A P Hospers, et al.Current Pharmaceutical Design|June 8, 2002
Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancerLing Chen, David J WaxmanCurrent Pharmaceutical Design|June 8, 2002
Protein interaction domain mapping for the selection of validated targets and lead compounds in the anti-infectious areaP Legrain, D StrosbergCurrent Pharmaceutical Design|January 29, 2002
As-needed use of benzodiazepines in managing clinical anxiety: incidence and implicationsH A Westra, S H StewartPageof 1,008